Cargando…

RWD129 A Comparison of ICU Admission Rate and Related Cost Among Patients Taking Nirmatrelvir and Ritonavir Combination Versus Molnupiravir for Treatment of Mild to Moderate COVID-19 in the US

Detalles Bibliográficos
Autores principales: Kukreja, I, Gaur, A, Upadhyay, N, Bhalani, S, Gupta, A, Verma, V, Pandey, S, Roy, A, Nayyar, A, Daral, S, Chawla, S, Mohanty, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747462/
http://dx.doi.org/10.1016/j.jval.2022.09.2354